Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: A Study of AMDX-2011P in Participants With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial AMDX-2011P in Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMDX-2011P

Snippet

Sponsor: Amydis Inc. | Conditions: Alzheimer Disease | Phase 2 | Status: RECRUITING